Prof. Dr. med. Lukas Flatz
Principal Investigator and Senior Consultant
attending physician
Dermatologie | Venerologie | Allergologie · Dept. IV
Evaluation des Einflusses von HLA-Genpolymorphismen auf das T-Zell-RezeptorRepertoire und T-Zell-Spezifitäten bei Patientinnen und Patienten mit nicht-kleinzelligem Lungenkarzinom unter Immun-Checkpoint-Inhibitor-Therapie
Jun 22, 2023
Fundamental Research - Jun 22, 2023 - Dec 31, 2024
Ongoing
Project leader: Flatz Lukas
Members: Sieber Pablo
Trispecific antibodies to target melanoma
Mar 7, 2023
Fundamental Research - Mar 7, 2023 - Dec 31, 2024
Ongoing
Project leader: Flatz Lukas
Members: Villiger Lukas
Identifying new therapeutic approaches targeting ErbB receptor family for melanoma patients with resistance to immunotherapy - a major unmet need
Jan 1, 2023
Fundamental Research - Jan 1, 2023 - Dec 31, 2025
Ongoing
Project leader: Flatz Lukas
The role of keratinocyte-differentiation antigens in head and neck squamous cell cancer
Nov 28, 2022
Fundamental Research - Nov 28, 2022 - Dec 31, 2024
Ongoing
Project leader: Flatz Lukas
The role of keratinocyte-differentiation antigens in head and neck squamous cell cancer
Nov 1, 2022
Fundamental Research - Nov 1, 2022 - Oct 30, 2025
Ongoing
Project leader: Flatz Lukas
Members: Stanossek Yves, Meili Samuel, Abdou Marie-Therese, Hasan Ali Omar
PH-L19IL2TNFNMSC-04/19 A phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions
Aug 2, 2020
Clinical Studies - Aug 2, 2020 - Jan 25, 2030
Ongoing
Project leader: Flatz Lukas
Immunmonitoring of patients before, during and after immunotherapy to predict anti-tumor response in melanoma and non-small cell lung cancer (IMIT)
Jul 15, 2016
Clinical Studies - Jul 15, 2016 - Oct 15, 2019
Automatically Closed
Project leader: Flatz Lukas
Members: Diem Stefan
Vaccine and immunotherapy induced CD8+ T cell responses against auto-, neo- and foreign antigens
Jan 1, 2016The growing incidence of melanoma is an increasing threat, and effective treatment options for advanced forms of melanoma are scarce. Although recently approved targeted- and immunotherapies have shown objective beneficial effects in metastatic melan...
Fundamental Research - Jan 1, 2016 - Dec 31, 2019
Automatically Closed
Project leader: Flatz Lukas
Members: Ring Sandra, Królik Michał Wojciech, Berner Fiamma